123 related articles for article (PubMed ID: 2856060)
1. Effect of labetalol on human platelet function.
Anfossi G; Trovati M; Lanzio M; Mularoni E; Massucco P; Emanuelli G
Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):437-48. PubMed ID: 2856060
[TBL] [Abstract][Full Text] [Related]
2. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
4. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375
[TBL] [Abstract][Full Text] [Related]
5. Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo.
Trovati M; Anfossi G; Cavalot F; Massucco P; Mularoni E; Emanuelli G
Diabetes; 1988 Jun; 37(6):780-6. PubMed ID: 2838353
[TBL] [Abstract][Full Text] [Related]
6. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
7. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
[TBL] [Abstract][Full Text] [Related]
9. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood.
Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G
Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784
[TBL] [Abstract][Full Text] [Related]
10. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
11. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effects of protopine isolated from Corydalis tubers.
Ko FN; Wu TS; Lu ST; Wu YC; Huang TF; Teng CM
Thromb Res; 1989 Oct; 56(2):289-98. PubMed ID: 2559491
[TBL] [Abstract][Full Text] [Related]
13. Adrenaline infusion evokes increased thromboxane B2 production by platelets in healthy men: the effect of beta-adrenoceptor blockade.
Laustiola K; Kaukinen S; Seppälä E; Jokela T; Vapaatalo H
Eur J Clin Invest; 1986 Dec; 16(6):473-9. PubMed ID: 2881786
[TBL] [Abstract][Full Text] [Related]
14. Effects of trifluoperazine on platelet activation.
Ardlie NG; Boatwright C; Garrett J; McGuiness JA
Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet aggregation by idebenone and the mechanism of the inhibition.
Suno M; Terashita Z; Nagaoka A
Arch Gerontol Geriatr; 1989 May; 8(3):313-21. PubMed ID: 2548448
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
Kerry R; Scrutton MC; Wallis RB
Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
[TBL] [Abstract][Full Text] [Related]
18. Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
Zahavi M; Rozen P; Zahavi J
Thromb Res; 1990 Aug; 59(3):693-9. PubMed ID: 2146767
[No Abstract] [Full Text] [Related]
19. Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.
Sengeløv H; Winther K
Eur J Clin Pharmacol; 1989; 37(5):453-7. PubMed ID: 2532135
[TBL] [Abstract][Full Text] [Related]
20. The effects of a combined alpha- and beta-blocking drug, labetalol, on some aspects of platelet function.
Lote K; Svenson B; Anstad U; Nordøy A
Thromb Haemost; 1978 Oct; 40(2):423-7. PubMed ID: 734639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
